Get the Stockscreener App
90.79
3.00%
-2.81
Pre-market:
90.39
-0.40
-0.44%
Iradimed Corp stock is traded at $90.79, with a volume of 158.20K.
It is down -3.00% in the last 24 hours and up +5.03% over the past month.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
See More
Previous Close:
$93.60
Open:
$93.87
24h Volume:
158.20K
Relative Volume:
1.34
Market Cap:
$1.16B
Revenue:
$86.28M
Net Income/Loss:
$23.61M
P/E Ratio:
49.45
EPS:
1.8359
Net Cash Flow:
$23.97M
1W Performance:
-3.81%
1M Performance:
+5.03%
6M Performance:
-6.42%
1Y Performance:
+56.08%
1-Day Range:
$90.25
$95.50
1-Week Range:
$90.25
$98.41
52-Week Range:
$55.11
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
90.79 | 1.16B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
IRADIMED CORP (IRMD) Stock Chart - ChartMill
Number of shareholders of IRadimed Corp. – DUS:46K - TradingView
Iradimed director sells $285,000 in company stock By Investing.com - Investing.com Australia
Insider Sell: Hilda Scharen-guivel Sells 3,000 Shares of iRadimed Corp (IRMD) - GuruFocus
Iradimed director sells $285,000 in company stock - Investing.com UK
IRADIMED (IRMD) director sells 3,000 shares in open-market trades - Stock Titan
IRMD (NASDAQ: IRMD) files notice to resell 285,000 common shares - Stock Titan
Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple - Yahoo Finance
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares - Investing.com
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares By Investing.com - Investing.com India
IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan - Stock Titan
IRADIMED CEO Sells 7500 Common Stock Shares - asatunews.co.id
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - Yahoo Finance
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - The Motley Fool
Iradimed Corp Quarterly Report Highlights Key Growth DriversEarnings Call Q&A - The Legal Advocate
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 - HarianBasis.co
IRMD Q1 2026 Earnings: EPS Beat of 7.95% Sends Stock LowerPeak Earnings Alert - newsline.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan - Stock Titan
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report - Insider Monkey
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? - sharewise.com
iRadimed (IRMD) Slips Amidst Sector Headwinds: Key Levels in FocusSweep Order Flow - The Legal Advocate
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed CEO Roger Susi sells $657,264 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Roger Susi sells $657,264 in company stock - Investing.com
CEO’s trust sells 7,500 IRADIMED (IRMD) shares under Rule 10b5-1 plan - Stock Titan
IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami - Stock Titan
iRadimed Corporation (IRMD) Crushes Q1 2026 Estimates — EPS $0.49 Tops ViewsEarnings Revision Downgrade - The Legal Advocate
Iradimed (NASDAQ: IRMD) family trusts disclose 4.45M shares, 34.8% ownership - Stock Titan
IRADIMED (IRMD) CEO Susi’s trust sells 7,500 pre-planned shares - Stock Titan
Reaffirmed Outlook And Dividend: What Does IRMD’s Confidence Signal About Its MRI Pump Moat? - Yahoo Finance
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 GuidanceLearn Why - Sahm
TradingKey - TradingKey
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD (iRadimed Corporation) beats Q1 estimates with 14.4% revenue growth, but shares dip despite strong results.Attention Driven Stocks - Newser
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness - Yahoo Finance
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Iradimed CEO Roger Susi sells $642,861 in company stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan - Stock Titan
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - Sahm
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
IRadimed Rides 3870 Momentum Despite Near-Term Dip - TipRanks
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):